Mon, Apr 21, 2014, 4:35 AM EDT - U.S. Markets open in 4 hrs 55 mins


% | $
Quotes you view appear here for quick access.

Prana Biotechnology Limited Message Board

zhidao90 83 posts  |  Last Activity: Mar 31, 2014 11:08 PM Member since: Oct 9, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Linda, pivalde, kadaicher, et. al.

    by goutah3006 Mar 31, 2014 1:25 PM
    zhidao90 zhidao90 Mar 31, 2014 11:08 PM Flag

    Like everyone else, I was shocked by the news this morning. I guess we dreamed about an island, but all we got was a bucket of sand.

    Maybe because of the seemingly endless delay in releasing the results, I decided to sell off a bit over the last few weeks. I still lost a little, but I feel like I dodged a bullet. For anyone who feels like they took a bullet this morning, well - been there, done that. I know how you're feeling right about now.

    But of course, so much more was at stake today besides the money. Most of the serious people here have been affected by AD in one way or another. And we go from hopeful to bewildered in the span of a moment. Strange feeling. It was too late for PBT2 to ever help my dad, but I felt like today, maybe we were turning a corner. Maybe we wouldn't have to fear the future quite so much. So much for that.

    Today was a cold and rainy day in Boston. Really depressing. Eight inches of water in the basement. I'll be pumping it out all night. But they say tomorrow should be sunny, and a little warmer.

  • Reply to

    Tanzi part 2

    by bostonbarginhunter Mar 23, 2014 5:18 PM
    zhidao90 zhidao90 Mar 23, 2014 5:47 PM Flag

    This is the AD 2.0 approach. PBT2 is the spearhead of that effort. It might be the first effective treatment for AD, but it certainly won't be the last.

    This is science at its best.

  • Reply to

    NY Times article today 3/19/14

    by jstrase Mar 19, 2014 9:49 PM
    zhidao90 zhidao90 Mar 19, 2014 10:32 PM Flag

    Interesting, of course. I would disagree with this statement though:

    “This is the first study that is really starting to provide a plausible pathway to explain why some people are more vulnerable to Alzheimer’s than other people.”

    The Metal Theory of AD attempts to explain this, and there's a wealth of solid research behind it. If REST is involved in AD, it will be many years, if ever, before it could provide a useful therapeutic. Meanwhile, IMAGINE results could be released tomorrow, and that could result in a paradigm shift in AD research, and a viable treatment within a few years.

    Don't get me wrong, this is interesting research. Maybe another piece of a complex puzzle. Maybe another dead end. It will be a long time before we know. On the other hand, in less than ten days, we'll know a lot more about the Metal Theory of AD. In fact, we know a lot more about the potential of PBT2 and the Metal Theory right now that we do about REST. So, far be it from me to give advice to the NYT, but I think there's a much bigger story out there. Where's the feature on PBT2?

    The mention of lithium is also interesting. Metals? AD?

  • Reply to

    Cost for Phase III trials - $26K per patient

    by iruleyoulose Mar 17, 2014 12:46 PM
    zhidao90 zhidao90 Mar 17, 2014 1:13 PM Flag

    If the IMAGINE results justify a move to phase 3, raising the cash to do it will not be a problem. It will be a risk-reward opportunity of a lifetime.

  • Reply to

    Analyst Comment this morning

    by spectracide Mar 17, 2014 9:16 AM
    zhidao90 zhidao90 Mar 17, 2014 10:07 AM Flag

    We don't know the results. Having said that, a 'big miss' is unlikely. Consider the doctors requesting the extension, Lawler, the earlier AD trial, Reach2HD, and so on. Anything is possible, but I don't think many informed people are expecting a big miss.

    When you consider the 'other' AD candidates, and use those failures to downplay PBT2's results - well, don't be so quick to do that. We learned from those failures, and that is part of what is driving the hope for PBT2. This drug works by a very different mechanism. Yes, clearing AB plaque is part of it, as with the other approaches. But it's much more than that. PBT2 is based on a well-developed (not complete) AD theory. They are not throwing something against the wall and hoping that it sticks. This is an AD 2.0 approach.

    Odds are very good that it's on to phase 3.

  • Reply to

    Shorts are not done with stock

    by olgagotthehots Mar 15, 2014 7:56 PM
    zhidao90 zhidao90 Mar 15, 2014 10:27 PM Flag

    Well, I think the point is that whether the stock is trading at 10 or 5 before the results, if the results are positive, it will be trading much, much higher afterwards. With the tremendous potential of this stock, the starting point doesn't matter as much as how far it will go if the results are good.

  • zhidao90 zhidao90 Mar 14, 2014 9:26 AM Flag

    You should have held out for more. I get $50,000 a month to drop my pearls of wisdom here on Yahoo MB. Can anyone beat that?

  • Reply to

    Julius.....Beware the Ides of March......

    by eawana Mar 13, 2014 5:45 PM
    zhidao90 zhidao90 Mar 13, 2014 11:12 PM Flag

    You scooped me, I was about to post the same thing!

    This time it ain't Julius, but the short-sellers who need to beware. You're about to be stabbed in the portfolio.

  • Reply to


    by tdeank1 Mar 12, 2014 10:12 PM
    zhidao90 zhidao90 Mar 13, 2014 11:01 PM Flag

    Very well said. And totally accurate.

  • zhidao90 zhidao90 Mar 10, 2014 11:15 AM Flag

    There's no doubt that extensive validation would be required, and that 90% is far less than optimal. But when you have nothing, something looks pretty good. It's a start. We could say the same thing about PBT2. It may not turn out to be a miracle cure, but on the other hand, it may turn out to be the starting point for effective treatment. That would still be an exciting development.

  • Reply to

    The Kindle eBook Is Back!

    by zhidao90 Feb 9, 2014 6:02 PM
    zhidao90 zhidao90 Mar 9, 2014 10:14 PM Flag

    It ain't a best seller yet, but one brick at a time. ;)

  • zhidao90 zhidao90 Mar 9, 2014 10:01 PM Flag

    So we may be closer than some think to the idea that you can take a test similar to cholesterol for cardiac disease, but instead of taking Lipitor if your results are too high, you take PBT2.

  • "A blood test that can detect Alzheimer’s disease up to three years before the onset of symptoms has been developed by scientists who believe that it could lead to the early diagnosis of progressive dementia in elderly people."

    "A team of researchers led by Howard Federoff of Georgetown University Medical Centre in Washington identified 10 lipids in the blood that can be used to detect the early signs of Alzheimer’s or other forms of dementia..."

    The link is enormous, so just Google it.

  • zhidao90 zhidao90 Mar 9, 2014 7:50 PM Flag

    Yeah, in the end, it's only the hard data that counts. And regarding that ... we shall know very soon.

  • zhidao90 zhidao90 Mar 9, 2014 7:35 PM Flag

    The two groups having the best insight as to the results would be the patient families and the doctors treating them.

    The families are keenly attuned to the day-to-day state of their AD relative. Even the most subtle change would be noticed. My dad recently began taking a new medication to treat his agitation, and wow, it was noticeable. You wouldn't have a clue anything had changed. I saw the unmistakable change in a matter of days.

    If my dad were taking PBT2, I would most certainly notice any change in him. No doubt. It's in the nature of the disease that you have to be tuned into the AD patient 24/7. You have to always know where they are, what they're doing, if they're hungry, if they're confused, if they're agitated, if they're content. It's part of the reason the disease is so taxing for the families. Any change, even slight, and you know it.

    The doctors are not wide-eyed optimists, they're applied scientists. That they recommended the extension, of course, speaks volumes. Just like an unemployment rate below 5% is essentially full-employment, the extension participation rate is essentially full participation. There are always circumstances where patients may decline to enroll. Maybe one or two placebo patients were too dull-witted to take the doctor's advice - I really, really, really (wink, wink, wink) think you should try PBT2.

    Anyway, without seeing the trial data, this is about as strong a signal as you can get that something very good is happening.

    FixingTheMetalBrain d-o,t c,o,m

    Sorry for the shameless plug.

  • Reply to

    Capturing the narrative

    by latebloomer4140 Mar 4, 2014 10:32 PM
    zhidao90 zhidao90 Mar 4, 2014 10:47 PM Flag

    Very well said. I was surprised to see Tanzi get into a Twitter war with AF on the big day. He is, after all, one of the most respected scientists in the field, and here he is knocking it back and forth with that two-bit twit. Yet, you could sense his anger. On such a hopeful day, he has to respond to an orchestrated attack by the likes of AF and company.

    Yet he has to respond. It's his life's work that's being smeared. Yeah, it was a smear job. Not everybody follows Prana and PBT2 as closely as we do, and if AF controls the narrative, then he's as believable as anybody else. You almost hate to even acknowledge the likes of AF, but you must. Expect more fireworks after the IMAGINE results.

  • zhidao90 zhidao90 Mar 4, 2014 2:15 PM Flag

    Remember just before the HD results were released, and Tanzi was putting out all those mysterious and giddy tweets. He was telling us something without actually saying it. He seems to be in that same giddy mood now. What's he telling us?

  • Reply to

    Whitehead Institute

    by jelchertjr Mar 4, 2014 11:11 AM
    zhidao90 zhidao90 Mar 4, 2014 11:20 AM Flag

    Nope. MegaBuster.

  • zhidao90 zhidao90 Mar 4, 2014 10:21 AM Flag

    Nice find indeed. Now, who you gonna believe - some twit from SA or scientists from the Whitehead Institute?

  • Reply to

    The race to buy shares before results

    by esoteric687 Feb 28, 2014 11:49 AM
    zhidao90 zhidao90 Feb 28, 2014 12:09 PM Flag

    With the Aussies markets open Sunday night in the USA, we may not even have to wait until Monday.

1.89+0.15(+8.62%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AstraZeneca PLC
NYSEThu, Apr 17, 2014 4:00 PM EDT
Urban Outfitters Inc.
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT